Showing 781 - 800 results of 1,854 for search '(( 1 11 decrease ) OR ( 10 ((greater decrease) OR (((mean decrease) OR (a decrease)))) ))*', query time: 0.17s Refine Results
  1. 781

    Influenza prevalence and vaccine efficacy among diabetic patients in Qatar by Swapna, Thomas

    Published 2023
    “…Among DM patients, influenza was the most prevalent respiratory pathogen at 48.9%. Influenza virus A (IVA) was the most circulating type, contributing to 38.4%, followed by IVB contributing to 10.4% of total respiratory infections. …”
    Get full text
    Get full text
    Get full text
  2. 782

    Influenza prevalence and vaccine efficacy among diabetic patients in Qatar by Swapna, Thomas

    Published 2023
    “…Among DM patients, influenza was the most prevalent respiratory pathogen at 48.9%. Influenza virus A (IVA) was the most circulating type, contributing to 38.4%, followed by IVB contributing to 10.4% of total respiratory infections. …”
    Get full text
    Get full text
    Get full text
    article
  3. 783
  4. 784
  5. 785
  6. 786
  7. 787
  8. 788
  9. 789

    Development of novel blend poly (Ethylene Glycol) / Poly(Ethersulfone) polymeric membrane using N-Methyl-2-Pyrollidone and dimethylformamide solvents for facilitating CO2/N2gas sep... by Juber, Fadel Abdul Hadi

    Published 2020
    “…According to the results, NMP/DMF solvent concentration was optimized at 20/40 NMP/DMF having obtained the highest CO2/N2 selectivity of 1.36 ± 0.01 and CO2 permeance of 6277.45 ± 11.0 GPU. …”
    Get full text
    Get full text
  10. 790
  11. 791
  12. 792
  13. 793

    Production and investigation of flexible nanofibers of sPEEK/PVP loaded with RuO2 nanoparticles by Chamakh, Mariem

    Published 2021
    “…The samples were synthesized with different concentrations of hydrous ruthenium chloride of 2 wt%, 5 wt%, and 10 wt%, and then annealed at a temperature of 300 �C for 4 h to form the ruthenium oxide nanoparticles. …”
    Get full text
    Get full text
  14. 794
  15. 795
  16. 796

    Is there truly an increase in risk of cardiovascular and hematological adverse events with vascular endothelial growth factor receptor tyrosine kinase inhibitors? by Furuya-Kanamori L.

    Published 2020
    “…Methods: A meta-analysis that included 71 trials, 8 different VEGFR-TKIs, and 11 adverse events were re-analyzed. The outcome of interest was re-defined as the complementary outcome (i.e. remaining free of an adverse event). …”
    Get full text
    Get full text
    Get full text
  17. 797
  18. 798
  19. 799
  20. 800